Aestas Pharma Inc.

Aestas Pharma dedicated to the development of novel first-in-class disease-modifying therapeutics for early-stage Alzheimer’s and Parkinson’s disease.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Boston, MA, USA
  • Currency USD
  • Founded July 2015
  • Employees 3
  • Incorporation Type C-corp
  • Website aestaspharma.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free